Perinatal brain injury and regulation of transcription

Ying Chao Chang, Chao Ching Huang

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Purpose of review: Perinatal hypoxic-ischemic brain injury is a major cause of mortality and morbidity in infants. The understanding of transcription factor activation leading to prosurvival gene expression is important as it pertains to the development of new therapy. Here, we highlight the regulation of transcription factors that potentially could promote neuro-survival in the immature brain. Recent findings: cAMP response element binding protein (CREB), nuclear factor-κB (NF-κB) and hypoxia-induciblefactor 1 (HIF-1) are developmentally regulated in the neural system, and are necessary for the induction of preconditioning against hypoxic-ischemia. CREB and NF-κB are also involved in the regulation of synaptic plasticity, and learning and memory. CREB phosphorylation is sufficient and necessary for survival in adult and immature neurons, and NF-κB activation in neurons could promote survival, whereas activation in glial cells enhances neuronal death. Although HIF-1 is necessary for hypoxic preconditioning, paradoxically, in the absence of preconditioning, this factor promotes ischemia-induced neuronal death. Erythropoietin, one of the HIF-1 targeted genes, is potently neuroprotective and may be beneficial in treating newborns with hypoxic-ischemic brain damage. Summary: Drugs that activate the specific signaling leading to the transcriptional activation of prosurvival genes may provide therapy for the treatment of perinatal hypoxic-ischemic brain injury. Investigation of the transcriptional mechanisms of neuro-survival is likely to reveal other novel transcription factors whose activation by small molecules or drugs will complement current medication in activating the salutary gene program.

Original languageEnglish
Pages (from-to)141-147
Number of pages7
JournalCurrent Opinion in Neurology
Volume19
Issue number2
DOIs
Publication statusPublished - Apr 2006
Externally publishedYes

Fingerprint

Cyclic AMP Response Element-Binding Protein
Brain Injuries
Transcription Factors
Transcriptional Activation
Ischemia
Genes
Neurons
Brain Hypoxia
Neuronal Plasticity
Erythropoietin
Neuroglia
Pharmaceutical Preparations
Therapeutics
Phosphorylation
Learning
Newborn Infant
Morbidity
Gene Expression
Mortality
Brain

Keywords

  • cAMP response element binding protein
  • Erythropoietin
  • Hypoxia-inducible factor 1
  • Hypoxic-ischemic brain injury
  • Nuclear factor-κB
  • Preconditioning
  • Transcription factor

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Perinatal brain injury and regulation of transcription. / Chang, Ying Chao; Huang, Chao Ching.

In: Current Opinion in Neurology, Vol. 19, No. 2, 04.2006, p. 141-147.

Research output: Contribution to journalArticle

@article{2388bf2f385d473984ddaabb518b2445,
title = "Perinatal brain injury and regulation of transcription",
abstract = "Purpose of review: Perinatal hypoxic-ischemic brain injury is a major cause of mortality and morbidity in infants. The understanding of transcription factor activation leading to prosurvival gene expression is important as it pertains to the development of new therapy. Here, we highlight the regulation of transcription factors that potentially could promote neuro-survival in the immature brain. Recent findings: cAMP response element binding protein (CREB), nuclear factor-κB (NF-κB) and hypoxia-induciblefactor 1 (HIF-1) are developmentally regulated in the neural system, and are necessary for the induction of preconditioning against hypoxic-ischemia. CREB and NF-κB are also involved in the regulation of synaptic plasticity, and learning and memory. CREB phosphorylation is sufficient and necessary for survival in adult and immature neurons, and NF-κB activation in neurons could promote survival, whereas activation in glial cells enhances neuronal death. Although HIF-1 is necessary for hypoxic preconditioning, paradoxically, in the absence of preconditioning, this factor promotes ischemia-induced neuronal death. Erythropoietin, one of the HIF-1 targeted genes, is potently neuroprotective and may be beneficial in treating newborns with hypoxic-ischemic brain damage. Summary: Drugs that activate the specific signaling leading to the transcriptional activation of prosurvival genes may provide therapy for the treatment of perinatal hypoxic-ischemic brain injury. Investigation of the transcriptional mechanisms of neuro-survival is likely to reveal other novel transcription factors whose activation by small molecules or drugs will complement current medication in activating the salutary gene program.",
keywords = "cAMP response element binding protein, Erythropoietin, Hypoxia-inducible factor 1, Hypoxic-ischemic brain injury, Nuclear factor-κB, Preconditioning, Transcription factor",
author = "Chang, {Ying Chao} and Huang, {Chao Ching}",
year = "2006",
month = "4",
doi = "10.1097/01.wco.0000218229.73678.a8",
language = "English",
volume = "19",
pages = "141--147",
journal = "Current Opinion in Neurology",
issn = "1350-7540",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Perinatal brain injury and regulation of transcription

AU - Chang, Ying Chao

AU - Huang, Chao Ching

PY - 2006/4

Y1 - 2006/4

N2 - Purpose of review: Perinatal hypoxic-ischemic brain injury is a major cause of mortality and morbidity in infants. The understanding of transcription factor activation leading to prosurvival gene expression is important as it pertains to the development of new therapy. Here, we highlight the regulation of transcription factors that potentially could promote neuro-survival in the immature brain. Recent findings: cAMP response element binding protein (CREB), nuclear factor-κB (NF-κB) and hypoxia-induciblefactor 1 (HIF-1) are developmentally regulated in the neural system, and are necessary for the induction of preconditioning against hypoxic-ischemia. CREB and NF-κB are also involved in the regulation of synaptic plasticity, and learning and memory. CREB phosphorylation is sufficient and necessary for survival in adult and immature neurons, and NF-κB activation in neurons could promote survival, whereas activation in glial cells enhances neuronal death. Although HIF-1 is necessary for hypoxic preconditioning, paradoxically, in the absence of preconditioning, this factor promotes ischemia-induced neuronal death. Erythropoietin, one of the HIF-1 targeted genes, is potently neuroprotective and may be beneficial in treating newborns with hypoxic-ischemic brain damage. Summary: Drugs that activate the specific signaling leading to the transcriptional activation of prosurvival genes may provide therapy for the treatment of perinatal hypoxic-ischemic brain injury. Investigation of the transcriptional mechanisms of neuro-survival is likely to reveal other novel transcription factors whose activation by small molecules or drugs will complement current medication in activating the salutary gene program.

AB - Purpose of review: Perinatal hypoxic-ischemic brain injury is a major cause of mortality and morbidity in infants. The understanding of transcription factor activation leading to prosurvival gene expression is important as it pertains to the development of new therapy. Here, we highlight the regulation of transcription factors that potentially could promote neuro-survival in the immature brain. Recent findings: cAMP response element binding protein (CREB), nuclear factor-κB (NF-κB) and hypoxia-induciblefactor 1 (HIF-1) are developmentally regulated in the neural system, and are necessary for the induction of preconditioning against hypoxic-ischemia. CREB and NF-κB are also involved in the regulation of synaptic plasticity, and learning and memory. CREB phosphorylation is sufficient and necessary for survival in adult and immature neurons, and NF-κB activation in neurons could promote survival, whereas activation in glial cells enhances neuronal death. Although HIF-1 is necessary for hypoxic preconditioning, paradoxically, in the absence of preconditioning, this factor promotes ischemia-induced neuronal death. Erythropoietin, one of the HIF-1 targeted genes, is potently neuroprotective and may be beneficial in treating newborns with hypoxic-ischemic brain damage. Summary: Drugs that activate the specific signaling leading to the transcriptional activation of prosurvival genes may provide therapy for the treatment of perinatal hypoxic-ischemic brain injury. Investigation of the transcriptional mechanisms of neuro-survival is likely to reveal other novel transcription factors whose activation by small molecules or drugs will complement current medication in activating the salutary gene program.

KW - cAMP response element binding protein

KW - Erythropoietin

KW - Hypoxia-inducible factor 1

KW - Hypoxic-ischemic brain injury

KW - Nuclear factor-κB

KW - Preconditioning

KW - Transcription factor

UR - http://www.scopus.com/inward/record.url?scp=33645070308&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645070308&partnerID=8YFLogxK

U2 - 10.1097/01.wco.0000218229.73678.a8

DO - 10.1097/01.wco.0000218229.73678.a8

M3 - Article

VL - 19

SP - 141

EP - 147

JO - Current Opinion in Neurology

JF - Current Opinion in Neurology

SN - 1350-7540

IS - 2

ER -